ROIV vs. RXRX

Last updated Aug 1, 2026

ROIV (Roivant Sciences Ltd.) and RXRX (Recursion Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, ROIV returned 41.65%/yr vs -39.89%/yr for RXRX. Their 0.39 correlation means their historical movements had little consistent relationship.

Performance

ROIV vs. RXRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Roivant Sciences Ltd. (ROIV) and Recursion Pharmaceuticals, Inc. (RXRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ROIV achieves a 56.27% return, which is significantly higher than RXRX's -26.65% return.

ROIV

• 1D: -1.77%
• 1M: -3.47%
• 6M: 56.85%
• YTD: 56.27%
• 1Y: 199.82%
• 3Y*: 41.65%
• 5Y*: —
• 10Y*: —
• ALL TIME*: 30.14%

RXRX

• 1D: -1.32%
• 1M: -21.05%
• 6M: -28.40%
• YTD: -26.65%
• 1Y: -47.18%
• 3Y*: -39.89%
• 5Y*: -37.05%
• 10Y*: —
• ALL TIME*: -35.29%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ROIV Roivant Sciences Ltd.	$157.54M	$163.14M	$184.93M
RXRX Recursion Pharmaceuticals, Inc.	$52.74M	$74.51M	$69.08M

ROIV vs. RXRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ROIV Roivant Sciences Ltd.	56.27%	83.43%	5.34%	40.55%	-20.73%	6.11%
RXRX Recursion Pharmaceuticals, Inc.	-26.65%	-39.50%	-31.44%	27.89%	-54.99%	-25.55%

Correlation

The correlation between ROIV and RXRX is 0.39, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.39
Correlation (3Y) Balances recent behavior with more history.	0.42
Correlation (All Time) Calculated using the full available price history since Oct 1, 2021	0.39

Fundamentals

Market Cap ROIV : $24.50B RXRX : $1.57B
EPS ROIV : -$0.43 RXRX : -$1.12
PS Ratio ROIV : 2.83K RXRX : 22.67
PB Ratio ROIV : 4.45 RXRX : 1.55
Total Revenue (TTM) ROIV : $8.26M RXRX : $66.29M
Gross Profit (TTM) ROIV : $6.98M RXRX : -$22.83M
EBITDA (TTM) ROIV : -$316.38M RXRX : -$505.90M

Return for Risk

ROIV vs. RXRX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ROIV

ROIV Risk / Return Rank: 99
ROIV Sharpe Ratio Rank: 99
ROIV Sortino Ratio Rank: 99
ROIV Omega Ratio Rank: 98
ROIV Calmar Ratio Rank: 99
ROIV Martin Ratio Rank: 99

RXRX

RXRX Risk / Return Rank: 13
RXRX Sharpe Ratio Rank: 12
RXRX Sortino Ratio Rank: 13
RXRX Omega Ratio Rank: 16
RXRX Calmar Ratio Rank: 10
RXRX Martin Ratio Rank: 14

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ROIV vs. RXRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Roivant Sciences Ltd. (ROIV) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ROIV	RXRX	Difference
Sharpe ratio: Return per unit of total volatility	4.72	-0.71	+5.43
Sortino ratio: Return per unit of downside risk	6.15	-0.96	+7.10
Omega ratio: Gain probability vs. loss probability	1.73	0.90	+0.82
Calmar ratio: Return relative to maximum drawdown	15.57	-0.85	+16.42
Martin ratio: Return relative to average drawdown	43.68	-1.25	+44.92

ROIV vs. RXRX - Sharpe Ratio Comparison

The current ROIV Sharpe Ratio is 4.72, which is higher than the RXRX Sharpe Ratio of -0.71. The chart below compares the historical Sharpe Ratios of ROIV and RXRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ROIV vs. RXRX - Drawdown Comparison

The maximum ROIV drawdown since its inception was -79.22%, smaller than the maximum RXRX drawdown of -93.13%. Use the drawdown chart below to compare losses from any high point for ROIV and RXRX.

Drawdown Indicators

	ROIV	RXRX	Difference
Max Drawdown Largest peak-to-trough decline	-79.22%	-93.13%	+13.91%
Max Drawdown (1Y) Largest decline over 1 year	-12.84%	-58.17%	+45.33%
Max Drawdown (3Y) Largest decline over 3 years	-36.47%	-81.70%	+45.23%
Max Drawdown (5Y) Largest decline over 5 years	—	-90.95%	—
Current Drawdown Current decline from peak	-7.88%	-92.74%	+84.86%
Average Drawdown Average peak-to-trough decline	-26.80%	-75.79%	+48.99%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.57%	39.99%	-35.42%

Volatility

ROIV vs. RXRX - Volatility Comparison

The current volatility for Roivant Sciences Ltd. (ROIV) is 10.12%, while Recursion Pharmaceuticals, Inc. (RXRX) has a volatility of 17.39%. This indicates that ROIV experiences smaller price fluctuations and is considered to be less risky than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ROIV	RXRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.12%	17.39%	-7.27%
Volatility (6M) Calculated over the trailing 6-month period	34.15%	45.40%	-11.25%
Volatility (1Y) Calculated over the trailing 1-year period	42.36%	69.61%	-27.25%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	59.98%	93.18%	-33.20%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	59.98%	92.91%	-32.93%

Dividends

ROIV vs. RXRX - Dividend Comparison

Neither ROIV nor RXRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ROIV and RXRX in my portfolio?

ROIV and RXRX have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ROIV or RXRX?

RXRX has higher volatility (17.39%) compared to ROIV (10.12%). In terms of maximum drawdown, ROIV dropped -79.22% vs RXRX's -93.13%.

Which has better risk-adjusted returns?

ROIV currently has the higher Sharpe Ratio (4.72 vs -0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.